Biotechnology Research, Medical and pharmaceutical research, Research and testing · 11 Employees
Phone Number: recruitment@enyopharma.com
Email Address: recruitment@enyopharma.com
Overview
Employees
Access 30 Verified Employees Profiles for Enyo PharmaUnlock Free Contacts Now
About
ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.
The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH).
Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.